1-4 of 4
Andy Chen, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Polatuzumab Vedotin Combined with Obinutuzumab for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma: Preliminary Safety and Clinical Activity of a Phase Ib/II Study

Tycel Phillips, MD, Mark Brunvand, MD, Andy Chen, MD PhD, Oliver Press, MD PhD, James Essell, MD, Annalisa Chiappella, MD, Catherine Diefenbach, MD, Surai Jones, MS Biostat, Jamie Hirata, PharmD, Ian W. Flinn, MD PhD
Journal: Blood
Blood (2016) 128 (22): 622.
https://doi.org/10.1182/blood.V128.22.622.622
Published: 2016
Journal Articles

Selective Targeting Cyclin-Dependent Kinase-9 (CDK9) Downmodulates c-MYC and Induces Apoptosis in Diffuse Large B-Cell Lymphoma (DLBCL) Cells

Taylor Rowland, Cody Paiva, BS, Joelle Rowley, Andy Chen, MD PhD, Lisa Drew, PhD, Peter Hurlin, Bill H. Chang, MD PhD, Alexey V Danilov, MD PhD
Journal: Blood
Blood (2016) 128 (22): 289.
https://doi.org/10.1182/blood.V128.22.289.289
Published: 2016
Journal Articles

Pralatrexate and Gemcitabine in Patients with Relapsed or Refractory Lymphoproliferative Malignancies: Phase 1 Results.

Steven M. Horwitz, MD, Julie M. Vose, M.D., Ranjana Advani, MD, Kamalesh Sankhala, MD, Swaminathan Padmanabhan, MD, Paul A. Hamlin, Jr., MD, Andy Chen, MD, PhD, Jasmine M Zain, MD, Steven Fruchtman, MD, Owen A O'Connor, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1674.
https://doi.org/10.1182/blood.V114.22.1674.1674
Published: 2009
Journal Articles

A Phase 1/2A Open-Label Study of Pralatrexate and Gemcitabine in Patients with Relapsed or Refractory Lymphoproliferative Malignancies.

Steven M. Horwitz, MD, Julie M. Vose, MD, Ranjana Advani, MD, Kamalesh Sankhala, MD, Swaminathan Padmanabhan, M.D., Paul A. Hamlin, Jr., MD, Andy Chen, MD, PhD, Shannon Wilroy, Jasmine M. Zain, MD, Danielle Wright, Hanna Weissbrot, Maribeth Hohenstein, Pablo J Cagnoni, MD, Michael E Saunders, MD, Owen A. O’Connor, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1570.
https://doi.org/10.1182/blood.V112.11.1570.1570
Published: 2008